描述
Winolap DS 5 ml Eye Drops (Olopatadine Hydrochloride Ophthalmic Solution 0.2% w/v) is a premium, once-daily dual-action antihistamine and mast cell stabilizer manufactured by Sun Pharmaceutical Industries Ltd. Formulated for the rapid and long-lasting relief of ocular itching associated with allergic conjunctivitis, Winolap DS represents the “Double Strength” (DS) evolution of olopatadine therapy, offering 24-hour symptom control with a single application.
1. Manufacturer Profile: Sun Pharmaceutical Industries Ltd
Sun Pharma is a global pharmaceutical leader, recognized for its advanced research in ophthalmic delivery systems and its high-purity active pharmaceutical ingredients (APIs).
- Manufacturing Excellence: Produced in world-class facilities that comply with WHO-GMP and international regulatory requirements, ensuring that every 5 ml bottle maintains clinical potency and sterility.
- Quality Assurance: Sun Pharma’s Winolap DS is engineered to be bioequivalent to global innovator brands, providing patients with gold-standard allergy relief.
2. Composition & Ingredients
Each 1 ml of Winolap DS contains:
- Active Ingredient: Olopatadine Hydrochloride IP equivalent to Olopatadine 2 mg (0.2% w/v).
- Preservative: Benzalkonium Chloride 0.01% w/v.
- Vehicle: pH-balanced sterile aqueous solution (pH range 6.5–7.5) designed for maximum ocular comfort.
3. Mechanism of Action: How It Works
Winolap DS utilizes a sophisticated dual-action pharmacology to target the allergic response at its source.
A. Selective H1 Receptor Antagonism
Olopatadine is a highly selective histamine H1 receptor antagonist. Upon instillation, it rapidly blocks the binding of histamine to the receptors on the ocular surface, providing immediate relief from intense itching and redness within minutes.
B. Mast Cell Stabilization
Unlike simple antihistamines, Winolap DS also stabilizes mast cells. It prevents the degranulation of these cells, thereby inhibiting the release of pro-inflammatory mediators such as prostaglandins and leukotrienes. This prevents the “late-phase” allergic reaction, ensuring that the eyes remain clear and itch-free for up to 24 hours.
4. Therapeutic Indications
Winolap DS 5 ml is clinically indicated for:
- Seasonal Allergic Conjunctivitis: Managing symptoms triggered by pollen, grass, and outdoor allergens.
- Perennial Allergic Conjunctivitis: Long-term relief from indoor triggers like dust mites, pet dander, and mold.
- Giant Papillary Conjunctivitis (GPC): Often used as part of a management plan for contact lens-related irritation.
5. Clinical Comparison: Winolap DS vs. Standard Olopatadine
| Feature | Winolap DS (0.2%) | Standard Winolap (0.1%) |
|---|---|---|
| Dosing Frequency | **Once Daily** | Twice Daily |
| Duration of Action | Up to 24 Hours | 8 to 12 Hours |
| Itch Relief Speed | Fast (within 2-5 mins) | Fast (within 2-5 mins) |
| Patient Adherence | **Superior** | Moderate |
6. Dosing & Administration
Recommended Dosage
- Adults and Children (3+ Years): One drop in each affected eye **once daily**.
Application Guidelines
- Wash hands thoroughly.
- Tilt the head back and gently pull the lower eyelid down.
- Instill one drop without touching the dropper tip to the eye or eyelashes.
- Close the eye for 1 to 2 minutes. Apply gentle pressure to the inner corner (tear duct) to maximize ocular retention.
- Wait at least 15 minutes before re-inserting contact lenses.
7. 注意事项与安全警告
- 隐形眼镜： 保存剂苯扎氯化铵可被软性隐形眼镜吸收。使用前请务必取下隐形眼镜。
- 年龄限制： 本药物在3岁以下儿童中的安全性和有效性尚未确立。
- 不良反应： 常见局部不良反应包括暂时性视力模糊、干眼或轻微的“异物感”。这些症状通常在几分钟内自行消退。
8. 经过充分研究的常见问答
问：我可以每天使用多次Winolap DS吗？
答： Winolap DS 特别配方为每日一次使用。更频繁使用通常不会提高疗效，反而可能增加局部刺激的风险。如症状持续，请咨询医生。
问：Winolap DS 是激素类药物吗？
答： 不是。Winolap DS 是抗组胺药和肥大细胞稳定剂，不含激素，也不具备长期使用激素类药物所带来的白内障或眼内压升高等风险。
问：使用Winolap DS后应在多久内丢弃开封的瓶子？
答： 像大多数眼科制剂一样，开封后请在30天内使用完毕，以确保药品的无菌性。
9. 官方监管文献
- Sun Pharma 眼科药品索引： 官方产品数据库
- 临床手册： Olopatadine Hydrochloride 0.2% 一日一次给药方案。
医学免责声明： 本内容由AI生成，仅用于教育目的，基于临床药学数据。本文不构成医疗建议。如需诊断或治疗，请务必咨询执业医疗专业人员。
评价
目前还没有评价